JMCP July 2025 Issue

Topic(s):

Managed Care Practice Issues

In this Issue

 

Viewpoint

Advancing the conversation: 30 years of scholarship in managed care pharmacy

L. Happe

Research

Health care resource utilization and costs in Medicare Advantage beneficiaries using glucagon-like peptide-1 receptor agonists vs sodium-glucose cotransporter-2 inhibitors

I. Poonawalla, P. Abdal, M. Hayes, I. John, M. Diaz, S. Dixon, and A. Bowe

Cost-effectiveness analysis model for sotagliflozin compared with insulin monotherapy for patients with type 1 diabetes and chronic kidney disease

J. Kim, S. Wang, M. Marin, S. Sikirica, M. Anderson, and J. Shafrin

The financial value of improving patient access to COVID-19 antiviral therapy in Medicare Part D: A simulation study

A. Aguilar, T. Engel, W. Furnback, G. Dieguez, D. Campbell, B. Diner, S. Sullivan, and W. Dorling

Cost per outcome of nivolumab + relatlimab vs BRAF + MEK inhibitor combinations for first-line treatment of BRAF-mutant advanced melanoma

K. Hanna, J. Palaia, D. Patel, A. Moshyk, Z. Zhou, F. Yang, Y. Xin, and V. Garcia-Horton

Budget impact analysis of revumenib for the treatment of relapsed or refractory acute leukemias with a KMT2A translocation in the United States

I. Abraham, P. Martin, S. Vaghela, T. Klein, E. Chow, M. Rush, R. Morlock, and H. Huang

Systematic Review

Associations between chronic active lesions and clinical outcomes in multiple sclerosis: A systematic literature review

F. Bagnato, M. Mordin, N. Greene, S. Mahida, and J. van Wingerden

Research Brief

Implementation of a nonstatin prior authorization checklist for patients with hypercholesterolemia: In 2 community health care systems

D. McCormick, P. Taub, J. Carter, K. Moreo, and C. Heggen

Perspectives on Value

The effectiveness and value of suzetrigine for moderate to severe acute pain: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council

D. Nikitin, D. Rind, B. McQueen, F. Raymond, S. Sanchez, M. DiStefano, A. Zemplenyi, W. Lee, and D. Ollendorf

COMPLETE ISSUE 

JMCP, July 2025, Volume 31, Number 7

 

 

Related

AMCP Legislative Brief - MVP Act of 2025 Update
Resource

Issue Brief - MVP Act of 2025

AMCP strongly supports the passage of the MVP Act. Medicaid beneficiaries are among America's most vulnerable patients. Value-based payment arrangements are a critical tool for promoting patient access to high-quality, affordable care.
Legislation & Regulation
AMCP Legislative Brief - Ensuring Community Access to Pharmacist Services Act Update
Resource

Issue Brief - Ensuring Community Access to Pharmacist Services Act

AMCP supports the Ensuring Community Access to Pharmacist Services Act. This bill will help ensure that Americans can continue to rely on pharmacists as essential partners in pandemic preparedness and response. The ECAPS Act will also improve patient access to tests and treatments by authorizing pharmacists to provide these services and receive reimbursement under Medicare Part B. The ECAPS Act addresses disparities in public health preparedness in medically underserved communities like rural areas by allowing these patients to seek care from their most accessible provider.
Legislation & Regulation

Upcoming Events

Visit the AMCP Calendar

AMCP offers a wide variety of educational opportunities, from events and webinars to online training.

Annual Conference:

Learn More
Nexus 2025 logo


October 27-30 • • • National, Harbor